Beckwith-Wiedemann Syndrome (BWS) is a rare genetic disorder that affects approximately 1 in 15,000 births. It is characterized by an overgrowth of certain parts of the body, including the organs, muscles, and bones. BWS can also cause a variety of other medical problems, including an increased risk of certain types of cancer. While the exact cause of BWS is unknown, it is believed to be caused by a genetic mutation. The diagnosis of BWS can be difficult, as the symptoms are often subtle and can vary from person to person. Additionally, the long-term effects of BWS are still being studied, making it difficult to predict the long-term prognosis. As a result, it is important for doctors to be aware of the complexities of BWS in order to provide the best possible care for patients.
The most common symptom of BWS is an overgrowth of certain parts of the body. This overgrowth can affect the organs, muscles, and bones, and can cause a variety of physical problems, including: • Macroglossia (enlarged tongue) • Low birth weight • Abdominal wall defects • Visible earlobes • Hypoglycemia (low blood sugar) • An enlarged liver and/or spleen • Developmental delays • Heart defects • Kidney abnormalities Other potential symptoms of BWS include an increased risk of certain types of cancer, such as Wilms tumor, hepatoblastoma, and adrenocortical carcinoma.
The diagnosis of BWS can be difficult, as the symptoms can vary from person to person and are often subtle. Additionally, BWS is often misdiagnosed due to its similarity to other conditions, such as Beckwith-Wiedemann-like syndrome and Sotos syndrome. In order to diagnose BWS, doctors will typically perform a physical examination to look for signs of overgrowth and other physical abnormalities. They may also order genetic testing, such as chromosomal microarray or karyotyping, to look for genetic mutations that are associated with BWS.
The treatment of BWS is focused on managing the overgrowth and associated medical problems. Depending on the severity of the symptoms, doctors may recommend medications, physical therapy, and/or surgery. For instance, if the overgrowth is causing breathing or feeding difficulties, doctors may prescribe medications to help with these issues. Additionally, physical therapy can help to strengthen weak muscles and improve coordination. In some cases, surgery may be necessary to correct physical abnormalities, such as abdominal wall defects.
The long-term prognosis of BWS is still being studied, as it is a relatively rare condition. However, most people with BWS have a normal life expectancy and can lead healthy, active lives. Additionally, it is important to note that BWS can increase the risk of certain types of cancer, such as Wilms tumor, hepatoblastoma, and adrenocortical carcinoma. Therefore, it is important for people with BWS to be monitored closely by their doctors in order to detect any potential signs of cancer.
Beckwith-Wiedemann Syndrome is a rare genetic disorder that affects approximately 1 in 15,000 births. It is characterized by an overgrowth of certain parts of the body, including the organs, muscles, and bones, and can cause a variety of medical problems. While the exact cause of BWS is unknown, it is believed to be caused by a genetic mutation. The diagnosis of BWS can be difficult, as the symptoms are often subtle and can vary from person to person. Additionally, the long-term effects of BWS are still being studied, making it difficult to predict the long-term prognosis. As a result, it is important for doctors to be aware of the complexities of BWS in order to provide the best possible care for patients. Treatment focuses on managing the overgrowth and associated medical problems, and most people with BWS have a normal life expectancy and can lead healthy, active lives. However, it is important to note that BWS can increase the risk of certain types of cancer, and therefore, it is important for people with BWS to be monitored closely by their doctors in order to detect any potential signs
1.
A single-cell analysis reveals a distinctive immunosuppressive tumor microenvironment in kidney cancer brain metastases.
2.
The FDA approves Enhertu for HER2-positive cancers, regardless of tumor type.
3.
Cancer diagnosis does not spur improvements to survivors' diets or eating habits
4.
According to a study by Amrita Hospital in Kochi, cancer mortality is rising among Indian women while declining for men.
5.
A garden can save your life
1.
Reshaping the Battlefield Through Tumor Microenvironment Modulation for Cancer Therapy
2.
Understanding Epoetin and Its Role in Treating Chronic Kidney Disease
3.
Biologic Therapies for Cutaneous Immune-Related Adverse Events in the Era of Immune Checkpoint Inhibitors
4.
Cracking the Code of Subdural Hematomas: Modern Strategies for Optimal Care
5.
Imaging in Peritoneal Neoplasms: Diagnostic Advances and Multimodal Treatment Strategies
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
A Panel Discussion on Clinical Trial End Point for Tumor With PPS > 12 months
2.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part V
3.
An In-Depth Look At The Signs And Symptoms Of Lymphoma- Further Discussion
4.
Incidence of Lung Cancer- An Overview to Understand ALK Rearranged NSCLC
5.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part III
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation